Literature DB >> 1804813

Hypoprothrombinemia from coadministration of sulofenur (LY 186641) and warfarin: report of three cases.

F V Fossella1, S M Lippman, D E Seitz, D S Alberts, C W Taylor, E Wiltshaw, J Hardy, M O'Brien, T R Haynes, R L Wolen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1804813     DOI： 10.1007/BF00183581

Source DB:  PubMed          Journal:  Invest New Drugs        ISSN： 0167-6997            Impact factor:   3.850


× No keyword cloud information.
  5 in total

1.  COMBINED EFFECT OF SODIUM WARFARIN AND PHENYLBUTAZONE.

Authors:  M J EISEN
Journal:  JAMA       Date:  1964-07-06       Impact factor: 56.272

2.  The effect of various drugs on the binding of warfarin-14C to human albumin.

Authors:  H M Solomon; J J Schrogie
Journal:  Biochem Pharmacol       Date:  1967-07-07       Impact factor: 5.858

3.  Potentiation of anticoagulant effect of warfarin by phenylbutazone.

Authors:  P M Aggeler; R A O'Reilly; L Leong; P E Kowitz
Journal:  N Engl J Med       Date:  1967-03-02       Impact factor: 91.245

4.  Clinical pharmacology of a novel diarylsulfonylurea anticancer agent.

Authors:  C W Taylor; D S Alberts; M A Ketcham; W G Satterlee; M T Holdsworth; P M Plezia; Y M Peng; T M McCloskey; D J Roe; M Hamilton
Journal:  J Clin Oncol       Date:  1989-11       Impact factor: 44.544

5.  The displacement of phenylbutazone-14C and warfarin-14C from human albumin by various drugs and fatty acids.

Authors:  H M Solomon; J J Schrogie; D Williams
Journal:  Biochem Pharmacol       Date:  1968-01       Impact factor: 5.858
  5 in total
  1 in total

Review 1.  Clinically significant drug interactions with the oral anticoagulants.

Authors:  M D Freedman; A G Olatidoye
Journal:  Drug Saf       Date:  1994-05       Impact factor: 5.606
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.